Home › NDC Lookup › RxCUI directory › RxCUI 151030

Mometasone furoate 1 MG/ML Topical Lotion — RxCUI 151030

RxNorm drug concept · Semantic clinical drug
RxCUI 151030 Semantic clinical drug · SCD ● Current RxNorm concept 7 FDA products 11 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI151030
Official nameMometasone furoate 1 MG/ML Topical Lotion
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmometasone furoate 0.1 % Topical Lotion; mometasone furoate 0.1 % Topical Solution (Lotion)
FDA products mapped7
Package NDCs mapped11
Reported Medicaid activity (SDUD)77,800 prescriptions · 43 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Mometasone Nasal Spray: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • You might start to notice some relief within 12 hours of your first dose, but the full effect usually kicks in after several days of using it regularly, once a day. It works best w...
  • How long does it take for this spray to start working?
  • Yes, it's designed for daily use, and for most people it's well tolerated over the long term at the recommended dose. That said, your doctor should check your nasal passages period...
  • Is it okay to use this spray every day long-term?
📖 Read our full Mometasone Nasal Spray guide →

🕸️ Concept Web — How Mometasone furoate 1 MG/ML Topical Lotion Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Mometasone furoate 1 MG/ML Topical Lotion RxCUI 151030

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Mometasone 108118
    • Mometasone furoate 30145
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Mometasone Topical Lotion 619119
    • Mometasone furoate Topical Lotion 2646452
    • Mometasone Topical Product 1165393
    • Mometasone furoate Topical Product 2661871
    • Topical Lotion 316983
    • Topical Product 1151122
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Mometasone furoate 1 MG/ML 358650

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Mometasone furoate 1 MG/ML SCDC · 358650
  • Mometasone Topical Lotion SCDF · 619119
  • Mometasone furoate Topical Lotion SCDFP · 2646452
  • Mometasone Topical Product SCDG · 1165393
  • Mometasone furoate Topical Product SCDGP · 2661871

📦 FDA Products & Package NDCs

7 products · 11 package NDCs
11 package NDCs map to RxCUI 151030 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
21922-0072-01 1 BOTTLE in 1 BOTTLE (21922-072-01) / 60 mL in 1 BOTTLE MOMETASONE FUROATE Encube Ethicals, Inc. 2025-01-22
21922-0072-21 1 BOTTLE in 1 CARTON (21922-072-21) / 30 mL in 1 BOTTLE MOMETASONE FUROATE Encube Ethicals, Inc. 2025-01-22
45802-0118-46 1 BOTTLE in 1 CARTON (45802-118-46) / 60 mL in 1 BOTTLE Mometasone Furoate Padagis Israel Pharmaceuticals Ltd 2008-12-11
45802-0118-59 1 BOTTLE in 1 CARTON (45802-118-59) / 30 mL in 1 BOTTLE Mometasone Furoate Padagis Israel Pharmaceuticals Ltd 2009-02-02
51672-1305-03 1 BOTTLE in 1 CARTON (51672-1305-3) / 30 mL in 1 BOTTLE Mometasone Furoate Sun Pharmaceutical Industries, Inc. 2006-03-15
51672-1305-04 1 BOTTLE in 1 CARTON (51672-1305-4) / 60 mL in 1 BOTTLE Mometasone Furoate Sun Pharmaceutical Industries, Inc. 2006-03-15
63629-8685-01 1 BOTTLE in 1 CARTON (63629-8685-1) / 30 mL in 1 BOTTLE Mometasone Furoate Bryant Ranch Prepack 2009-02-02
68462-0385-02 1 BOTTLE in 1 CARTON (68462-385-02) / 60 mL in 1 BOTTLE Mometasone Furoate Glenmark Pharmaceuticals Inc., USA 2020-06-01
68462-0385-37 1 BOTTLE in 1 CARTON (68462-385-37) / 30 mL in 1 BOTTLE Mometasone Furoate Glenmark Pharmaceuticals Inc., USA 2020-06-01
72162-1392-03 1 BOTTLE in 1 CARTON (72162-1392-3) / 30 mL in 1 BOTTLE Mometasone Furoate Bryant Ranch Prepack 2023-08-16
72162-1392-06 1 BOTTLE in 1 CARTON (72162-1392-6) / 60 mL in 1 BOTTLE Mometasone Furoate Bryant Ranch Prepack 2023-08-16
Observed labelers: Bryant Ranch Prepack (3) · Encube Ethicals, Inc. (2) · Glenmark Pharmaceuticals Inc., USA (2) · Padagis Israel Pharmaceuticals Ltd (2) · Sun Pharmaceutical Industries, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.